Document Detail


Effects of inhibitors on aldolase breakdown after its microinjection into HeLa cells.
MedLine Citation:
PMID:  2655577     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The regulation of protein breakdown as well as the generation of intermediates in the pathway from intact protein to amino acids was investigated by using 3H-labelled N-ethylmaleimide-modified aldolase (NEM-aldolase) as an indicator protein after its microinjection into HeLa cells. 2. NEM-aldolase degradation to acid-soluble products proceeded at a slower rate than that of endogenously labelled total cell protein, and was inhibited to a greater extent by 3-methyladenine, leupeptin and NH4Cl. The combination of leupeptin plus NH4Cl was particularly effective, decreasing the NEM-aldolase breakdown rate by 90%. 3. Measurements of the loss of radioactivity from the aldolase band located from fluorograms after SDS/polyacrylamide-gel electrophoresis showed that NEM-aldolase breakdown was much more rapid when measured by this method. The effects of insulin, 3-methyladenine, leupeptin and NH4Cl on this breakdown were also substantial. 4. Substantial amounts of peptide intermediates in the breakdown pathway of NEM-aldolase accumulated in cells. The production of small intermediates (less than 30 kDa) accounted for approx. 40% of the NEM-aldolase degraded in control cultures. Addition of NH4Cl increased the proportion of these intermediates. Large intermediates, between 31 and 38 kDa, were particularly evident in the presence of the cysteine proteinase inhibitor leupeptin, but almost no small intermediates were detected. 5. The results are best explained by the degradation of NEM-aldolase being predominantly a lysosomal process, with cysteine proteinases involved in early proteolytic steps and other proteinases that have acid pH optima required for the complete catabolism of small intermediates.
Authors:
S E Knowles; M F Hopgood; F J Ballard
Related Documents :
17627477 - The role of autophagy in mediating cell survival and death during ischemia and reperfus...
17202707 - Compressed oxygen in drug stability experiments.
22900597 - Thermal tolerance and survival of cronobacter sakazakii in powdered infant formula supp...
22459847 - Rumen and milk odd- and branched-chain fatty acid proportions are minimally influenced ...
22910957 - Review: omega-3 fatty acid supplements provide no protective benefit in cardiovascular ...
6118867 - Uptake of aspartic and glutamic acid by photoreceptors in goldfish retina.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Biochemical journal     Volume:  259     ISSN:  0264-6021     ISO Abbreviation:  Biochem. J.     Publication Date:  1989 Apr 
Date Detail:
Created Date:  1989-06-15     Completed Date:  1989-06-15     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2984726R     Medline TA:  Biochem J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  27-33     Citation Subset:  IM    
Affiliation:
CSIRO Division of Human Nutrition, Adelaide, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenine / analogs & derivatives,  pharmacology
Ammonium Chloride / pharmacology
Ethylmaleimide / metabolism
Fructose-Bisphosphate Aldolase / antagonists & inhibitors*,  metabolism
Hela Cells
Humans
Insulin / pharmacology
Leupeptins / pharmacology
Microinjections
Chemical
Reg. No./Substance:
0/Leupeptins; 11061-68-0/Insulin; 12125-02-9/Ammonium Chloride; 128-53-0/Ethylmaleimide; 5142-23-4/3-methyladenine; 73-24-5/Adenine; EC 4.1.2.13/Fructose-Bisphosphate Aldolase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Food quality and "health nutrition"--a challenge for agriculture and food processing
Next Document:  Effect of the antibiotic purpuromycin on cell-free protein-synthesizing systems.